肺状细胞癌在初始治疗6年后对nivolumab重复治疗有反应:一个病例报告
Kento Kono1, Kazuhisa Nakashima2, Yukari Tsubata2
1Department of Respiratory Medicine, National Hospital Organization Hamada Medical Center, Hamada, Japan.
Thoracic cancer
|July 3, 2024
概括
这项研究强调了一名肺癌患者,在经过广泛的先前化疗后,他获得了对尼沃卢马布的持久完整反应. 用nivolumab重复治疗也在经过显著的无药间隔后导致完全反应.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 一名患有晚期肺状细胞癌 (cT2aN3M1a阶段) 的患者,尽管接受了多次化疗,但病情进展.
- 作为第五线治疗,使用免疫检查点抑制剂 (ICI) Nivolumab.
研究的目的:
- 在长时间停用免疫检查点抑制剂后,在LSCC中报告一个对尼沃卢马布完全反应的罕见病例.
- 评估nivolumab重复治疗在患有复发性LSCC的患者中的疗效和安全性.
主要方法:
- 一个61岁的男性患者的病例报告,患有转移的LSCC.
- 顺序化疗治疗,其次是尼沃卢马布 (第五线疗法).
- 肺炎的管理,其次是无治疗间隔,随后在疾病复发时重新治疗nivolumab.
主要成果:
- 最初的nivolumab治疗实现了持续2年8个月的完全响应 (CR).
- 由于肺炎,经过3年8个月的无治疗间隔后,nivolumab重新治疗再次诱导了CR.
- 在重新治疗后,CR持续超过1年6个月,表明持续的疗效.
结论:
- 尼沃卢马布可以在先进的LSCC中诱导显著和持久的反应,即使在长时间的ICI-free间隔后.
- 对那些最初对ICI治疗反应良好的患者来说,用尼沃卢马布重新治疗可能是一个可行的和有效的策略.
- 这一案例凸显了ICI可能带来的持续益处,以及在治疗复发性或耐火性癌症时考虑重新治疗选择的重要性.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K